Anavex Life Sciences AVXL
NASDAQ AVXL
$1.89 -0.13 (-6.44%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anavex Life Sciences (AVXL) Accounts Payables (2011 - 2026)

Updated

Anavex Life Sciences' Accounts Payables was $3.66 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 45.8% from $6.74 million a year earlier but up 45.1% from the prior quarter.

Analysis

Anavex Life Sciences (AVXL) Accounts Payables (2011 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Accounts Payables at Anavex Life Sciences came in at $4.25 million, down 55.9% from FY2024.

  • Accounts Payables shows a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
  • In earlier fiscal years, Accounts Payables was $9.63 million in FY2024 (+122.7%), $4.32 million in FY2023 (+13.0%), $3.83 million in FY2022 (-19.3%) and $4.74 million in FY2021 (+18.8%).
  • Quarterly Accounts Payables has moved between $2.52 million (fiscal Q2 2026) and $9.63 million (fiscal Q4 2024) over five years.
  • Compared with a year earlier, Accounts Payables has declined for four straight quarters, with growth averaging 12.7% over the last eight quarters.
  • The best year-over-year quarter for Accounts Payables over five years was fiscal Q2 2023 (growth of 138.7%); the worst was fiscal Q2 2026 (a decline of 64.0%).
  • Per Business Quant data, AVXL's Accounts Payables in the three fiscal quarters before Q3 2026 was $2.52 million (Q2 2026), $2.64 million (Q1 2026) and $4.25 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Anavex Life Sciences 187.25 Mn -292.83 Mn - 3.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.66 Mn
Mar 31, 2026 2.52 Mn
Dec 31, 2025 2.64 Mn
Sep 30, 2025 4.25 Mn
Jun 30, 2025 6.74 Mn
Mar 31, 2025 7.00 Mn
Dec 31, 2024 4.57 Mn
Sep 30, 2024 9.63 Mn
Jun 30, 2024 3.50 Mn
Mar 31, 2024 3.73 Mn
Dec 31, 2023 4.29 Mn
Sep 30, 2023 4.32 Mn
Jun 30, 2023 4.15 Mn
Mar 31, 2023 6.28 Mn
Dec 31, 2022 5.29 Mn
Sep 30, 2022 3.83 Mn
Jun 30, 2022 3.13 Mn
Mar 31, 2022 2.63 Mn
Dec 31, 2021 4.63 Mn
Sep 30, 2021 4.74 Mn
API Access

Anavex Life Sciences Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=AVXL&period=max&api_key=YOUR_API_KEY